Related content

Defining predictive values using three different platelet function tests for CYP2C19 phenotype status on maintenance dual antiplatelet therapy after PCI

By Zhang Hong-Zhe   Kim Moo Hyun   Han Jin-Yeong   Jeong Young-Hoon  

Platelets, Vol. 25, Iss. 4, 2014-06 ,pp. : 285-291

Informa Healthcare

Access to resources Recommend Favorite

High frequency of CYP2C19*2 carriers in PCI-treated patients switched over from clopidogrel to prasugrel based on platelet function monitoring

By Bernlochner Isabell   Mayer Katharina   Morath Tanja   Braun Siegmund   Schulz Stefanie   Schömig Albert   Koch Werner   Kastrati Adnan   Sibbing Dirk  

Platelets, Vol. 24, Iss. 6, 2013-09 ,pp. : 500-502

Informa Healthcare

Access to resources Recommend Favorite

Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel

By Mangiacapra Fabio  

Journal of Thrombosis and Thrombolysis, Vol. 32, Iss. 1, 2011-07 ,pp. : 54-58

Springer Publishing Company

Access to resources Recommend Favorite

Platelet function measured by VerifyNow™ identifies generalized high platelet reactivity in aspirin treated patients

By Dichiara Joseph   Bliden Kevin P.   Tantry Udaya S.   Chaganti Srivasavi K.   Kreutz Rolf P.   Gesheff Tania B.   Geshefe Tania.A.   Kreutz Yvonne   Gurbel Paul A.  

Platelets, Vol. 18, Iss. 6, 2007-09 ,pp. : 414-423

Informa Healthcare

Access to resources Recommend Favorite

Sulfonylureas and on-clopidogrel platelet reactivity in type 2 diabetes mellitus patients

By Harmsze Ankie M.   Van Werkum Jochem W.   Moral Fulya   Ten Berg Jurriën M.   Hackeng Christian M.   Klungel Olaf H.   De Boer Anthonius   Deneer Vera H. M.  

Platelets, Vol. 22, Iss. 2, 2011-03 ,pp. : 98-102

Informa Healthcare

Access to resources Recommend Favorite